OPHTHOTECH CORP's ticker is OPHT and the CUSIP is 683745103. A total of 57 filers reported holding OPHTHOTECH CORP in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $516,000 | -46.7% | 366,100 | -54.6% | 0.00% | – |
Q4 2018 | $968,000 | -57.2% | 806,610 | -15.8% | 0.00% | -100.0% |
Q3 2018 | $2,261,000 | -4.5% | 958,137 | +10.5% | 0.00% | 0.0% |
Q2 2018 | $2,367,000 | +53.4% | 867,096 | +53.9% | 0.00% | 0.0% |
Q1 2018 | $1,543,000 | +166.0% | 563,271 | +202.8% | 0.00% | – |
Q4 2017 | $580,000 | – | 186,004 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 2,053,143 | $95,533,000 | 31.57% |
Clarus Ventures, LLC | 1,554,744 | $72,342,000 | 30.07% |
Novo Holdings A/S | 4,910,487 | $228,485,000 | 19.43% |
JHL Capital Group LLC | 3,265,000 | $151,920,000 | 13.98% |
AlpInvest Partners B.V. | 37,500 | $1,745,000 | 3.26% |
Opaleye Management Inc. | 105,000 | $4,886,000 | 2.27% |
IMA Wealth, Inc. | 67,930 | $3,161,000 | 1.54% |
Hillview Capital Advisors, LLC | 34,830 | $1,621,000 | 1.40% |
Cheyne Capital Management (UK) LLP | 124,151 | $5,777,000 | 1.39% |
WILLIAM HARRIS INVESTORS INC | 106,158 | $4,939,000 | 1.30% |